Cerevel Stock Soars Ahead Of Parkinson s Drug Update - Hold (NASDAQ:CERE) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
The latest deals will see the biotech division of the Samsung Group produce biosimilar products ranging from oncology and inflammation to immunotherapy in the period to 2029 at its new Plant 4 in South Korea. Coherus BioSciences launches biosimilar version of AbbVie's blockbuster Humira Coherus BioSciences said on Monday it has launched a copycat version of AbbVie's Humira in the United States at a discount of more than 85% to the blockbuster arthritis drug.
The latest deals will see the biotech division of the Samsung Group produce biosimilar products ranging from oncology and inflammation to immunotherapy in the period to 2029 at its new Plant 4 in South Korea. Coherus BioSciences launches biosimilar version of AbbVie's blockbuster Humira Coherus BioSciences said on Monday it has launched a copycat version of AbbVie's Humira in the United States at a discount of more than 85% to the blockbuster arthritis drug.